The healthcare world is witnessing a significant shift in diabetes therapy with the introduction of GLP-1 transdermal devices. These systems offer a possibly more user-friendly alternative to injections of GLP-1 drugs, lessening the frequency of daily needle sticks. The technology delivers the drug directly through the epidermis, possibly enhancing